State LA
Clinical Trials in Louisiana
Recruiting clinical trials with at least one study location in Louisiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Louisiana
Malignant Solid Neoplasm (4)Lung Non-Small Cell Carcinoma (2)Melanoma (2)Non-Hodgkin Lymphoma (2)Chronic Lymphocytic Leukemia (2)Hidradenitis Suppurativa (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Myeloid Leukemia (2)Pressure Injury (2)Cardiovascular Diseases (2)Overweight (2)Obesity (2)
NCT06252753 N/A
Recruiting
Observational Study Protocol: LIVER-R
Condition
Hepatobiliary Cancers
Enrollment
4,490 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06794541 Phase 2
Recruiting
A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Pat...
Condition
Complicated Intra-abdominal Infections (cIAI)
Enrollment
35 pts
Location
United States
Sponsor
Tetraphase Pharmaceuticals, In
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT02555280 N/A
Recruiting
Coflex PS3 Actual Conditions for Use Study
Condition
Spinal Stenosis Lumbar
Enrollment
300 pts
Location
United States
Sponsor
Xtant Medical
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT05275686 Phase 2
Recruiting
Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eusta...
Condition
Eustachian Tube Dysfunction
Enrollment
80 pts
Location
United States
Sponsor
Cedars-Sinai Medical Center
NCT06819007 Phase 3
Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy ...
Condition
Ovarian Cancer
Enrollment
582 pts
Location
United States, Australia, Austria
Sponsor
Daiichi Sankyo
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT02843945 Phase 1, Phase 2
Recruiting
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With ...
Condition
Pancreatic Cancer
Enrollment
80 pts
Location
United States
Sponsor
CivaTech Oncology
NCT06866405 Phase 3
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vac...
Condition
RSV Infection
Enrollment
550 pts
Location
United States, Argentina, South Africa
Sponsor
Pfizer
NCT05491525 Phase 2, Phase 3
Recruiting
A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years ...
Condition
Neurogenic Detrusor Overactivity
Enrollment
85 pts
Location
United States
Sponsor
Urovant Sciences GmbH
NCT07287644 Phase 2, Phase 3
Recruiting
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Condition
Hidradenitis Suppurativa (HS)
Enrollment
210 pts
Location
United States
Sponsor
Bluefin Biomedicine, Inc.
NCT03695978 N/A
Recruiting
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untre...
Condition
Haemophilia A
Enrollment
200 pts
Location
United States, Argentina, Azerbaijan
Sponsor
Octapharma
NCT04956549 N/A
Recruiting
Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Imp...
Condition
Dementia of Alzheimer Type
Enrollment
144 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06232304 N/A
Recruiting
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythemato...
Condition
Systemic Lupus Erythematosus of Childhood (Disorder)
Enrollment
175 pts
Location
United States, Canada
Sponsor
Michigan State University
NCT04814420 N/A
Recruiting
Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study
Condition
Atrial Fibrillation
Enrollment
60 pts
Location
United States
Sponsor
Tulane University
NCT06118515 Phase 1
Recruiting
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cy...
Condition
Congenital Cytomegalovirus Infection
Enrollment
12 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06819891 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (...
Condition
Moderately to Severely Active Crohns Disease
Enrollment
425 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT06345690 N/A
Recruiting
VIA Disc NP Registry 3.0
Condition
Discogenic Pain
Enrollment
500 pts
Location
United States
Sponsor
VIVEX Biologics, Inc.
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals